Inclusion Criteria:
  -  Female and male subjects aged 18 years or older
  -  Diabetes mellitus Type 1 as definded by WHO for at least 2 years or C-peptide negative (<100 pmol/L with concomitant blood glucose > 4 mmol/L)
  -  hybrid-closed-loop Insulin therapy (Minimed 670G) for at least 2 months
  -  HbA1c <= 9 %
  -  The subject is willing and capable of adhering to the diet plan.
Exclusion Criteria:
  -  Physical or psychological condition likely to interfere with the normal conduct of the study and interpretation of the study results as judged by the investigator.
  -  Excess alcohol consumption (> 3 units/day for men, > 2 units/day for women)
  -  Pregnancy, planned pregnancy or breast feeding
  -  Current participation in another clinical trial
  -  Total daily insulin dose >2 IU/kg/day
  -  Nephrolithiasis
  -  Hereditary dyslipidemia
  -  Liver steatosis